Cardiovascular disease is a leading cause of death in China. AI Nurse is a digital health app, the result of a collaboration between Novartis and Tencent, that leverages the WeChat social media platform to make it easier for patients with heart failure and other cardiovascular disorders to manage disease progression.
Published on 16/02/2022
Text by Andrew Joyce, Photos by Getty Images for Novartis
Mr. Zhang, a heart failure patient, cooks in his kitchen. Hospitals enroll patients with AI Nurse after treatment for a cardiac event. Patients send regular updates to their doctor via an AI-enabled chatbot, which provides medication reminders and recommendations for diet and exercise.
Mr. Zhang, a keen gardener, gathers onions grown in his yard in Shenyang.
Dr. Yang Gao at a hospital in Shenyang. Dr. Gao is one of 5000 healthcare professionals at over 1000 hospitals across 200 cities in China using AI Nurse to help their patients manage cardiovascular disease progression.
Dr. Gao examines data from the AI Nurse app during a consultation with her patient, Mr. Zhang. AI Nurse alerts doctors to signs of deterioration, helping to determine if follow-up care is needed.
Mr. Zhang and his wife leave a hospital in Shenyang.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.